Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

NIH 11OTHER 8NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 5Neuroblastoma 4Ganglioneuroblastoma 4Breast Neoplasms 4Prostatic Neoplasms 3Medulloblastoma 3Wilms Tumor 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Mouth Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Embryonal 2Carcinoma 2Burkitt Lymphoma 2Astrocytoma 2Uterine Cervical Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Seizures 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1

Interventions

Platinum 3Cisplatin 31,2-diaminocyclohexaneplatinum II citrate 3Taxes 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Magnetic Resonance Spectroscopy 2Carboplatin 2sargramostim 1pembrolizumab 1dehydroftorafur 1X-Rays 1Specimen Handling 1Radiotherapy, Image-Guided 1Radiation 1Polymerase Chain Reaction 1Pilocarpine 1Paclitaxel 1N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1Gene Expression Profiling 1Fluorouracil 1Fenretinide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Mouth Neoplasms × Magnetic Resonance Spectroscopy × Clear all
NCT05721755 2026-05-05

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
290 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT06084845 2024-07-25

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer

Eastern Cooperative Oncology Group

Phase 2 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡